Introduction: Photodynamic therapy (PDT) is a therapeutic option in patients with a superficial esophageal cancer. Recently, PDT was shown to be effective as a salvage therapy for a local recurrence after chemoradiotherapy (CRT).

Aim: To compare retrospectively the results and the complications rate of PDT between consecutive patients treated in primary intent for a superficial esophageal cancer versus patients treated by PDT for a local recurrence after CRT.

Methods: Between 1999 and 2007 in a single center, 40 consecutive patients were treated by PDT for a superficial esophageal cancer, 25 (group 1) in primary intent and 15 (group 2) for a local recurrence after CRT. Two days after intravenous (IV) Photofrin (2 mg/kg), the phototherapy was performed with a dye laser. The treatment response and severe complications, defined as perforation and stricture requiring endoscopic dilation, were compared between the two groups.

Results: The patient and tumor characteristics were not different between the two groups. In group 1, 19 out of 25 patients (76%) were successfully treated versus 8 out of 15 patients (53%) in group 2 (P= 0.17). Severe complications occurred more frequently in patients with a prior CRT (8%vs 46.7%, P= 0.008) and included two perforations and five strictures requiring endoscopic dilation, while only two strictures occurred in group 1. A prior CRT was an independent risk factor of severe complications (odds ratio [OR] 8.05; 95% confidence interval [CI]1.22-43.0).

Conclusions: Severe complications were significantly more frequent in patients treated after a prior CRT. PDT as a salvage therapy in patients with a local recurrence after CRT for esophageal cancer tended to be less efficient than in first-line treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2008.02042.xDOI Listing

Publication Analysis

Top Keywords

esophageal cancer
20
severe complications
20
patients treated
20
superficial esophageal
16
local recurrence
16
primary intent
12
prior crt
12
patients
10
patients superficial
8
photodynamic therapy
8

Similar Publications

RNA Modification and Digestive Tract Tumors: A Review.

Curr Med Chem

January 2025

Department of Infectious Diseases, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471000, Henan, China.

Gastrointestinal tumors, including colorectal and liver cancer, are among the most prevalent and lethal solid tumors. These malignancies are characterized by worsening prognoses and increasing incidence rates. Traditional therapeutic approaches often prove ineffective.

View Article and Find Full Text PDF

Esophagectomy for Cancer After One Anastomosis Gastric Bypass.

Ann Thorac Surg Short Rep

September 2023

Division of Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.

One anastomosis gastric bypass (OAGB) is growing in popularity, although it is potentially associated with biliary gastritis and gastroesophageal reflux esophagitis, with a potential rise in esophageal carcinoma. We describe the surgical management of a 53-year-old man with history of OAGB in whom biliary reflux and esophageal adenocarcinoma developed. We performed a minimally invasive Ivor Lewis esophagectomy, resected the sleeved stomach pouch, created a new conduit out of the remnant greater curve of the remnant stomach with blood supply from an intact gastroepiploic artery, and created an esophagogastric anastomosis.

View Article and Find Full Text PDF

Background: The objective of this study was to compare generative artificial intelligence-initiated care pathways, using ChatGPT, with expert-guided consensus-initiated care pathways from AskMayoExpert (AME) for symptom management of esophageal cancer patients after esophagectomy.

Methods: A formal protocol for development of 9 AME care pathways was followed for specific patient-identified domains after esophagectomy for esophageal cancer. Domain scores were measured and assessed through the Upper Digestive Disease tool.

View Article and Find Full Text PDF

Impact and Durability of the Affordable Care Act Medicaid Expansion on Lung Cancer Treatment.

Ann Thorac Surg Short Rep

December 2024

Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.

Background: Medicaid expansion began in 2014 after passage of the Affordable Care Act; however, the impact and durability of the effects on lung cancer treatment utilization are poorly defined. We aimed to determine whether there is a persistent difference in utilization of lung resection, lung biopsy, and nonoperative treatment of lung cancer in states participating in Medicaid expansion compared with states that are not.

Methods: A retrospective cohort study was completed analyzing the difference in utilization between Medicaid expansion states and non-expansion states in 2012-2013, 2016-2017, and 2019.

View Article and Find Full Text PDF

Two Roads to Diagnose Primary Esophageal Adenoid Cystic Carcinoma in the Mediastinum.

Ann Thorac Surg Short Rep

March 2023

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Veterans Administration Hospital, VA Caribbean Health Care System, San Juan, Puerto Rico.

Adenoid cystic carcinoma (ACC) is a malignant epithelial tumor that predominantly originates in the salivary glands of the head and neck. However, ACC arising in the thoracic cavity is a rare entity. Diagnosis of primary esophageal ACC (EACC) involves use of gastrointestinal endoscopic ultrasound fine-needle aspiration; however a low diagnostic yield has been reported in the literature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!